Catalyst Wire Dossier Catalyst Wire Dossier

SIM0811 Injection

SIM0811 · Jiangsu Simcere Pharmaceutical Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SIM0811 Injection, covering 2026-01-15 to 2026-01-15. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single Ascending Doses of SIM0811 Injection in Healthy Chinese Adult Subjects [Phase 1]

See pricing